• CLSI EP23-P

CLSI EP23-P

Laboratory Quality Control Based on Risk Management; Proposed Guideline, EP23PE

Clinical and Laboratory Standards Institute, 01/01/2010

Publisher: CLSI

File Format: PDF

$103.00$207.39


Published:01/01/2010

Pages:102

Clinical and Laboratory Standards Institute document EP23-P--Laboratory Quality Control Based on Risk Management; Proposed Guideline provides guidance to laboratories on the development of quality control plans for measuring systems. Regulatory requirements, information provided by the manufacturer, information pertaining to the laboratory environment, and medical requirements for the test results are evaluated using risk management principles to develop a quality control plan tailored to the particular combination of measuring system, laboratory environment, and clinical application. The effectiveness of the laboratory quality control plan is monitored to detect trends, identify corrective actions, and provide continuous quality improvement. The advantages and limitations of various quality control processes are considered. Clinical and Laboratory Standards Institute (CLSI). Laboratory Quality Control Based on Risk

More CLSI standard pdf

CLSI VET02-A3

CLSI VET02-A3

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline - Third Edition, VET02A3E

$90.00 $180.00

CLSI I/LA30-A

CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

$108.00 $216.21

CLSI M23-A3

CLSI M23-A3

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline--Third Edition, M23A3E

$145.00 $290.74

CLSI M50-A (R.2018)

CLSI M50-A (R.2018)

Quality Control for Commercial Microbial Identification Systems; Approved Guideline, M50AE

$90.00 $180.00